BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:America/Phoenix
X-WR-TIMEZONE:America/Phoenix
BEGIN:VEVENT
UID:2024@azbio.org
DTSTART;TZID=America/Phoenix:20260917T081500
DTEND;TZID=America/Phoenix:20260917T163000
DTSTAMP:20260222T010336Z
URL:https://www.azbio.org/events/2026-arizona-alzheimers-consortium-scient
 ific-conference
SUMMARY:2026 Arizona Alzheimer’s Consortium Scientific Conference - Unive
 rsity of Arizona Student Union - 17 Sep 26 08:15
DESCRIPTION:[caption id="attachment_48786" align="alignnone" width="800"] I
 mage courtesy of the Arizona Alzheimer's Consortium[/caption]\n2026 Arizon
 a Alzheimer’s Consortium Scientific Conference\n&nbsp\;\nRegistration is
  now open for the Arizona Alzheimer's Consortium 2026&nbsp\;Annual Scienti
 fic Conference&nbsp\;hosted by University of Arizona.\n\nWHEN\nThursday\, 
 September 17\, 2026\n\n8:15 AM - 4:30 PM\n\nWHERE\nUniversity of Arizona\n
 Student Union Grand Ballroom\n1303 E. University Blvd\, Tucson\, AZ 85719\
 nREGISTER&nbsp\;\n&nbsp\; &nbsp\; &nbsp\; &nbsp\; &nbsp\; &nbsp\; &nbsp\; 
 &nbsp\; &nbsp\; &nbsp\;\nKEYNOTE\n\nReisa Sperling\, MD\nProfessor of Neur
 ology\, Harvard Medical School\nDirector\, Center for Alzheimer Research a
 nd Treatment\nBrigham and Women's Hospital and Massachusetts General Hospi
 tal\nDr. Reisa Sperling is a neurologist focused on the detection and trea
 tment of Alzheimer’s disease (AD) at the earliest possible stage\, even 
 before clinical symptoms are apparent. Dr. Sperling is a Professor in Neur
 ology at Harvard Medical School\, and the Director of the Center for Alzhe
 imer Research and Treatment (CART) at Brigham and Women’s Hospital and M
 assachusetts General Hospital.&nbsp\; Dr. Sperling is the co-Principal Inv
 estigator (with her husband Keith Johnson) of the NIH funded Harvard Aging
  Brain Study. Dr. Sperling chaired the 2011 NIA-Alzheimer’s Association 
 workgroup to develop guidelines for the study of “Preclinical Alzheimer
 ’s disease\,” and co-led the workgroup that defined “Amyloid Related
  Imaging Abnormalities (ARIA) the same year. She co-led the Anti-Amyloid T
 reatment in Asymptomatic Alzheimer’s disease (A4) Study\, the first prev
 ention trial is sporadic preclinical (“presymptomatic”) AD\, and the c
 ompanion LEARN Study\, and has made the A4/LEARN longitudinal data publicl
 y available to researchers from around the world. Dr. Sperling co-leads th
 e NIH funded Alzheimer’s Clinical Trial Consortium (ACTC)\, and the publ
 ic-private partnership AHEAD 3-45 Study prevention trials\, testing target
 ed dosing of lecanemab in early and late stages of preclinical AD\, as wel
 l as the Alzheimer Plasma Extension (APEX) Study working towards primary p
 revention trials for AD.\n&nbsp\;\n\nPLUS\nPoster presentations\nData blit
 z presentations\nWrap-up session
CATEGORIES:AZ- South
LOCATION:University of Arizona Student Union\, 1303 E. University Blvd\, Tu
 cson\, AZ\, 85719\, United States
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=1303 E. University Blvd\, T
 ucson\, AZ\, 85719\, United States;X-APPLE-RADIUS=100;X-TITLE=University o
 f Arizona Student Union:geo:0,0
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Phoenix
X-LIC-LOCATION:America/Phoenix
BEGIN:STANDARD
DTSTART:20250917T081500
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR